Revision as of 20:55, 8 March 2014 editRenamed user 51g7z61hz5af2azs6k6 (talk | contribs)6,460 edits →Metformin: new section← Previous edit | Revision as of 20:55, 8 March 2014 edit undoWhiskeyseed (talk | contribs)9 edits →Tread carefully when criticizing Arbcom: new sectionNext edit → | ||
Line 176: | Line 176: | ||
I realize that I'm splitting hairs here over a second tier drug. But am aiming for consistency. Best ] (]) 20:55, 8 March 2014 (UTC) | I realize that I'm splitting hairs here over a second tier drug. But am aiming for consistency. Best ] (]) 20:55, 8 March 2014 (UTC) | ||
== Tread carefully when criticizing Arbcom == | |||
I agree with your questioning Arbcom but I wanted to stop by and give you a freindly suggestion to be careful. They have access to every tool and are allowed extremely wide latitude when doing things. They are generally above reproach and as you have seen much of their discussions are offline making it difficult to proove if their intent is for the betterment of the project or something personal. I have long though that Arbcom needs major reform, unfortunately the only ones who can do that currently are the WMF and much of the community is afraid to speak out against them. Those who do are usually banned. As you can see by AGK's comments, they start by eroding the editors standing in the project by making insinuations and accusations that are based on policy but are often out in left field if you catch my meaning. Good luck. ] (]) 20:55, 8 March 2014 (UTC) |
Revision as of 20:55, 8 March 2014
Translation Main page | Those Involved (sign up) | Newsletter |
Glycyrrhetinic acidHi, rofl, yet again I need to ask your opinion. The glycyrrhetinic acid page's name does not reflect the INN of this drug which is enoxolone. Do you think I would be justified in moving the page? Fuse809 (talk) 08:36, 24 February 2014 (UTC)
Yet again there's a redirect page so I need you to do the move, please. Fuse809 (talk) 20:58, 24 February 2014 (UTC) I think you must have missed this message as I see you've done edits since I left this so I'm hoping a second message will grab your attention. Fuse809 (talk) 02:22, 25 February 2014 (UTC)
Oh, rofl. Sorry. Didn't see that. Thanks. Fuse809 (talk) 03:09, 25 February 2014 (UTC) Thank you for the responseDr. James, many thanks for your response. May I email you to continue this discussion? What is your address? — Preceding unsigned comment added by Roguemed87 (talk • contribs) 09:39, 26 February 2014 (UTC)
Reverted editHi Jmh649, can you revert your edit ? See Talk:Birth_control#Reverted_edit Thanks, KVDP (talk) 10:57, 26 February 2014 (UTC)
Use of MEDRS and durabilityThe arguments here seem to be a bit of a stretch. Any suggestions? Thanks Jim1138 (talk) 17:15, 26 February 2014 (UTC)
Question about class of our group projectOfficial title of the class is Movement Anatomy. We're learning about the muscles in our body and which movements they cause. Our group project was to choose a research topic dealing with muscles and/or overall movement. Our group chose cerebral palsy. Shankguam (talk) 15:55, 27 February 2014 (UTC) WP:MEDRS talk pageI raised a question over there on which your thoughts would be greatly appreciated. At the bottom of the page, MEDRS and Toxicology. Formerly 98 (talk) 16:40, 27 February 2014 (UTC) Medical questionHi. I see you are an M.D. I go to 12th grade of High School, a some-kind-of medical secondary school where we go to become nurses. (There are also some other departments such as those for laboratory technicians, pharmaceutical technicians, sanitary technicians, look up.) Anyway, I had this oral examination in Internal medicine, I didn't know the answer for this question ″What can be seen by biopsy in Chrohn’s disease?″. So I'm looking for a reference. I couldn't find the right answer, so can you give me one? Cheers, Alex 21:12, 27 February 2014 (UTC)
The Signpost: 26 February 2014
Why can't I refute a secondary source with a primary source?hihi, you left a message for me earlier? Usong725 (talk) 09:15, 28 February 2014 (UTC) re reverted edits on "Diabetic ketoacidosis" and "Osteonecrosis of the jaw"Hi, can you please explain why the edits on the said topics were reverted? Thank you Usong725 (talk) 09:24, 28 February 2014 (UTC)
Early detectionHi Doc. Thanks for your message... you're right. Regarding the sentence "Unfortunately, because of a lack of early detection strategies, the disease is usually advanced when the diagnosis is made", there are two options. I could change it to something like "Unfortunately, because most countries do not perform routine screening for gastric cancer, the disease is usually advanced when the diagnosis is made" or I could just change it back to "Unfortunately, because early stomach cancer causes few symptoms, the disease is usually advanced when the diagnosis is made." The first option sounds like a plug for gastric endoscopes, so I'll go with option 2. Hope that's okay. TTFN, Alan Merrit (talk) 13:27, 28 February 2014 (UTC)
Hi again. Thanks for replying. I'm not an expert but it's my understanding prevalence of the disease within the target population is just one of many variables considered when deciding whether or not to screen. Other factors include sensitivity, specificity, safety, acceptability, cost of the screening test within the target population, also safety, efficacy, & cost of the treatment for the disease within the target population, fiscal resources of the country, whether healthcare in the country is predominantly private/public etc. Over time, screening tests and treatments both improve, and there comes a point when it makes sense to screen. I suspect this might be too complex an issue to include within the gastric carcinoma article. Up to you though. Have a good weekend. Alan Merrit (talk) 14:14, 1 March 2014 (UTC)
Ultimatum'Dumbledore says people find it far easier to forgive others for being wrong than being right,' said Hermione, of J. K. Rowling fame, in the Half-Blood Prince, on page ninety-five. If you want to sell optimism and likely ultimate causes, then you will accept cancellation of your work.
Okay so why do we use review articles rather than primary sources here at WikiProject Medicine? Review articles generally give a better overview of all the literature on a topic. Some studies find positive results other find negative results. Good review articles take all these into account and give them proper balance. Systematic reviews are deemed to be the best source of information for specific questions. Literature reviews are better for a general overview. Doc James (talk · contribs · email) (if I write on your page reply on mine) 23:34, 4 March 2014 (UTC)
You are more than welcome to ask for further opinions at WT:MED. Doc James (talk · contribs · email) (if I write on your page reply on mine) 00:32, 5 March 2014 (UTC)
For what content? Often review articles will state by how much something changes risk. Doc James (talk · contribs · email) (if I write on your page reply on mine) 00:54, 5 March 2014 (UTC)
DOIHi, James, yet again I require your opinion. The DOI page is currently using a chembox, but as it's a recreationally used drug I think a drugbox might be more appropriate; what do you think? Fuse809 (talk) 05:18, 4 March 2014 (UTC)
Edit reversionYou should have left a message on the editor's talk page to explain this reversion, especially when the editor is new to Misplaced Pages. Axl ¤ 13:09, 4 March 2014 (UTC)
refs?What is it that you want references for? — Preceding unsigned comment added by Sjones008 (talk • contribs) 07:28, 5 March 2014 (UTC)
Regarding alkalinization of urine and uric acid stones, I'm right. The correction I was making was the previous version reported xanthine oxidase inhibition to be the primary therapy which is wrong. The reference shows that there is dramatic melting of large stones with alkalinization. — Preceding unsigned comment added by Jtopf (talk • contribs) 07:21, 8 March 2014 (UTC)
Suggestions? — Preceding unsigned comment added by Jtopf (talk • contribs) 07:29, 8 March 2014 (UTC)
MetforminHi Doc, Thanks for your help with the Saxagliptin article, and with the other gliptin articles which I assume you reviewed as well. I don't mean to be argumentative, but the most recent meta analyses I was able to find indicate no CV benefit for metformin or one that is just barely statistically significant and only in monotherapy. http://www.ncbi.nlm.nih.gov/pubmed/22517929 http://www.ncbi.nlm.nih.gov/pubmed/22509138 http://www.ncbi.nlm.nih.gov/pubmed/21205121. I realize that I'm splitting hairs here over a second tier drug. But am aiming for consistency. Best Formerly 98 (talk) 20:55, 8 March 2014 (UTC) Tread carefully when criticizing ArbcomI agree with your questioning Arbcom but I wanted to stop by and give you a freindly suggestion to be careful. They have access to every tool and are allowed extremely wide latitude when doing things. They are generally above reproach and as you have seen much of their discussions are offline making it difficult to proove if their intent is for the betterment of the project or something personal. I have long though that Arbcom needs major reform, unfortunately the only ones who can do that currently are the WMF and much of the community is afraid to speak out against them. Those who do are usually banned. As you can see by AGK's comments, they start by eroding the editors standing in the project by making insinuations and accusations that are based on policy but are often out in left field if you catch my meaning. Good luck. Whiskeyseed (talk) 20:55, 8 March 2014 (UTC) |